The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Thrombin modulates and reverses neuroblastoma neurite outgrowth.
Open accessAbstract
Previous studies have shown that neuroblastoma cells and several types of primary neuronal cells in culture rapidly extend neurites when switched from serum-containing to serum-free medium. The present studies on cloned neuroblastoma cells show that thrombin blocked this spontaneous differentiation at 2 nM with a half-maximal potency of 50 pM. This required the catalytic activity of thrombin and was reversed upon thrombin removal. Thrombin also caused cells in serum-free medium to retract their neurites at equally low concentrations. Two other serine proteases, urokinase and plasmin, did not block or reverse neurite extension even at 100-fold higher concentrations. A specific assay for thrombin indicated that thrombin detected in serum-containing medium from neuroblastoma cultures was derived from serum and that it was likely responsible for much of the known capacity of serum to maintain neuroblastoma cells in a nondifferentiated state. This was supported by the finding that heparin addition reduced the thrombin concentration in serum-containing medium and stimulated neurite outgrowth from neuroblastoma cells in serum-containing medium. Studies on the ability of thrombin to modulate neurite outgrowth by other agents showed that it blocked and reversed the neurite outgrowth activity of two thrombin inhibitors: protease nexin-1 (which is identical to glial-derived neurite-promoting factor) and hirudin. Thrombin, however, did not block the neurite-promoting activity of dibutyryl cAMP or prostaglandin E1. These results suggest a specific role for thrombin in control of neurite outgrowth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
Bottenstein, J. E., & Sato, G. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.514 · Cited by 2,276
Clonal cell lines from the rat central nervous system
Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick, J., Steinbach, J. H., Culp, W., & Brandt, B. L. (1974) · Nature · doi:10.1038/249224a0 · Cited by 712
Neurotransmitter Synthesis by Neuroblastoma Clones
Amano, T., Richelson, E., & Nirenberg, M. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.258 · Cited by 688
ESTABLISHMENT OF FUNCTIONAL CLONAL LINES OF NEURONS FROM MOUSE NEUROBLASTOMA
Augusti-Tocco, G., & Sato, G. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.1.311 · Cited by 484
Regulation of Axon Formation by Clonal Lines of a Neural Tumor
Seeds, N. W., Gilman, A. G., Amano, T., & Nirenberg, M. W. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.1.160 · Cited by 476
Plasminogen Activator Release at the Neuronal Growth Cone
Krystosek, A., & Seeds, N. W. (1981) · Science · doi:10.1126/science.7197054 · Cited by 392
PRASAD, K. N., & HSIE, A. W. (1971) · Nature New Biology · doi:10.1038/newbio233141a0 · Cited by 378
In vitro DIFFERENTIATION OF A MOUSE NEUROBLASTOMA
Schubert, D., Humphreys, S., Baroni, C., & Cohn, M. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.64.1.316 · Cited by 307
Gioor, S., Odink, K., Guenther, J., Nick, H., & Monard, D. (1986) · Cell · doi:10.1016/0092-8674(86)90511-8 · Cited by 296
A glia-derived neurite-promoting factor with protease inhibitory activity.
Guenther, J., Nick, H., & Monard, D. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03878.x · Cited by 264
Cited by
Proteinase-activated Receptors
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Déry, O., Corvera, C. U., Steinhoff, M., & Bunnett, N. W. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.6.c1429 · Cited by 779
Proteinase-Activated Receptors
Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D., & Plevin, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01493-5 · Cited by 641
Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., Luger, T. A., & Hollenberg, M. D. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0025 · Cited by 501
A player of many parts: The spotlight falls on thrombin's structure
Stubbs, M. T., & Bode, W. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90002-6 · Cited by 441
Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor
Nostrand, W. E. V., Wagner, S. L., Suzuki, M., Choi, B. H., Farrow, J. S., Geddes, J. W., Cotman, C. W., & Cunningham, D. D. (1989) · Nature · doi:10.1038/341546a0 · Cited by 438
Self-citationGlycosaminoglycans and the regulation of blood coagulation
Bourin, M. C., & Lindahl, U. (1993) · Biochemical Journal · doi:10.1042/bj2890313 · Cited by 419
Revisiting the conversion of muscle into meat and the underlying mechanisms
Ouali, A., Herrera-Mendez, C. H., Coulis, G., Becila, S., Boudjellal, A., Aubry, L., & Sentandreu, M. A. (2006) · Meat Science · doi:10.1016/j.meatsci.2006.05.010 · Cited by 407
Baranes, D., Lederfein, D., Huang, Y.-Y., Chen, M., Bailey, C. H., & Kandel, E. R. (1998) · Neuron · doi:10.1016/s0896-6273(00)80597-8 · Cited by 405
More to “heparin” than anticoagulation
Lindahl, U., Lidholt, K., Spillmann, D., & Kjellén, L. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90136-8 · Cited by 340
Prothrombin mRNA is expressed by cells of the nervous system
Dihanich, M., Kaser, M., Reinhard, E., Cunningham, D., & Monard, D. (1991) · Neuron · doi:10.1016/0896-6273(91)90060-d · Cited by 338
Self-citationCellular consequences of thrombin-receptor activation
GRAND, R. J. A., TURNELL, A. S., & GRABHAM, P. W. (1996) · Biochemical Journal · doi:10.1042/bj3130353 · Cited by 334
Synthesis and release of neuroactive substances by glial cells
Martin, D. L. (1992) · Glia · doi:10.1002/glia.440050202 · Cited by 316
Lo, E. H., Wang, X., & Cuzner, M. L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10270 · Cited by 310
Donovan, F. M., Pike, C. J., Cotman, C. W., & Cunningham, D. D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05316.1997 · Cited by 304
Self-citationChondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
Rhodes, K. E., & Fawcett, J. W. (2004) · Journal of Anatomy · doi:10.1111/j.1469-7580.2004.00261.x · Cited by 296
Serine proteases and brain damage – is there a link?
Gingrich, M. B., & Traynelis, S. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01617-9 · Cited by 274
Vaughan, P., Pike, C., Cotman, C., & Cunningham, D. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05389.1995 · Cited by 272
Self-citationProtease-activated receptors in health and disease
Peach, C. J., Edgington-Mitchell, L. E., Bunnett, N. W., & Schmidt, B. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00044.2021 · Cited by 116
Thrombin, a mediator of neurotoxicity and memory impairment
Mhatre, M., Nguyen, A., Kashani, S., Pham, T., Adesina, A., & Grammas, P. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.07.007 · Cited by 105
Licastro, F., Mallory, M., Hansen, L. A., & Masliah, E. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00096-4 · Cited by 70
Metadata
- Authors
- Gurwitz, D., & Cunningham, D. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1988-05
- Volume
- 85
- Issue
- 10
- Pages
- 3440-3444
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1983447138
- Cited by
- 318
- References
- 22
- FWCI
- 19.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.